Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-08
DOI
10.3389/fimmu.2021.676686
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BTK blockers make headway in multiple sclerosis
- (2021) Elie Dolgin NATURE BIOTECHNOLOGY
- Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS
- (2020) Darius Häusler et al. Neurology-Neuroimmunology & Neuroinflammation
- The transcription factor Hhex cooperates with the corepressor Tle3 to promote memory B cell development
- (2020) Brian J. Laidlaw et al. NATURE IMMUNOLOGY
- Ofatumumab versus Teriflunomide in Multiple Sclerosis
- (2020) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infection and Activation of B Cells by Theiler’s Murine Encephalomyelitis Virus (TMEV) Leads to Autoantibody Production in an Infectious Model of Multiple Sclerosis
- (2020) Young-Hee Jin et al. Cells
- Tailoring B cell depletion therapy in MS according to memory B cell monitoring
- (2020) Giovanni Novi et al. Neurology-Neuroimmunology & Neuroinflammation
- A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis
- (2020) Akshaya Ramesh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B cells reappear less mature and more activated after their anti-CD20–mediated depletion in multiple sclerosis
- (2020) Nitzan Nissimov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis.
- (2020) David Baker et al. Multiple Sclerosis and Related Disorders
- Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10
- (2019) Olga L. Rojas et al. CELL
- Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires
- (2019) Hemangi B. Shah et al. Frontiers in Immunology
- Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients
- (2019) Silvia Medina et al. Annals of Clinical and Translational Neurology
- Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease
- (2019) James Keaney et al. Journal of Neuroimmune Pharmacology
- Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis
- (2019) Krista D. DiSano et al. Journal of Neuroinflammation
- Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis
- (2019) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination
- (2019) Anna-Karin E. Palm et al. Frontiers in Immunology
- Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases
- (2019) Richard D. Caldwell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis
- (2019) Krista D. DiSano et al. Frontiers in Immunology
- Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis
- (2019) D. Baker et al. EUROPEAN JOURNAL OF NEUROLOGY
- Long-term use of interferon-β in multiple sclerosis increases Vδ1−Vδ2−Vγ9− γδ T cells that are associated with a better outcome
- (2019) Guzailiayi Maimaitijiang et al. Journal of Neuroinflammation
- Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients
- (2019) Jan W. Traub et al. Journal of Neuroinflammation
- Neutrophils promote VLA-4–dependent B cell antigen presentation and accumulation within the meninges during neuroinflammation
- (2019) Chelsea R. Parker Harp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ZBTB32 restrains antibody responses to murine cytomegalovirus infections, but not other repetitive challenges
- (2019) Arijita Jash et al. Scientific Reports
- The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells
- (2018) Joana Machado-Santos et al. BRAIN
- Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
- (2018) Bryan Ceronie et al. JOURNAL OF NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis
- (2018) Amit Bar-Or et al. NEUROLOGY
- Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
- (2018) Ivan Jelcic et al. CELL
- Cladribine Tablets: A Review in Relapsing MS
- (2018) Emma D. Deeks CNS DRUGS
- B-cell composition in the blood and cerebrospinal fluid of multiple sclerosis patients treated with dimethyl fumarate
- (2018) Rune A. Høglund et al. Multiple Sclerosis and Related Disorders
- Dynamics of Virus-Specific Memory B Cells and Plasmablasts following Viral Infection of the Central Nervous System
- (2018) Jeffrey R. Atkinson et al. JOURNAL OF VIROLOGY
- Effector and regulatory B cells in immune-mediated kidney disease
- (2018) Kristine Oleinika et al. Nature Reviews Nephrology
- An optimized method for enumerating CNS derived memory B cells during viral-induced inflammation
- (2017) Krista D. DiSano et al. JOURNAL OF NEUROSCIENCE METHODS
- Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
- (2017) Mark A Agius et al. Multiple Sclerosis Journal
- Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis
- (2017) Laura E. Baldassari et al. Neurotherapeutics
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
- (2017) Mark A Agius et al. Multiple Sclerosis Journal
- Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis
- (2017) Andreas Lossius et al. Annals of Clinical and Translational Neurology
- Dimethyl fumarate alters B-cell memory and cytokine production in MS patients
- (2017) Matthew D. Smith et al. Annals of Clinical and Translational Neurology
- Multiple sclerosis: experimental models and reality
- (2016) Hans Lassmann et al. ACTA NEUROPATHOLOGICA
- Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis
- (2016) Fabiana Rizzo et al. IMMUNOLOGY AND CELL BIOLOGY
- Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis
- (2016) Rui Li et al. JOURNAL OF IMMUNOLOGY
- Regulated selection of germinal-center cells into the memory B cell compartment
- (2016) Ryo Shinnakasu et al. NATURE IMMUNOLOGY
- Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
- (2016) Ding Chen et al. Journal of Clinical Medicine
- MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changes
- (2015) Manuel Comabella et al. HUMAN MOLECULAR GENETICS
- IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity
- (2015) Ryan D. Schubert et al. JOURNAL OF IMMUNOLOGY
- The effect of B-cell depletion in the Theiler's model of multiple sclerosis
- (2015) Francesca Gilli et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
- (2015) Roberto Bomprezzi Therapeutic Advances in Neurological Disorders
- Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins
- (2015) Simon N. Willis et al. Frontiers in Immunology
- Combination of TACI-IgG and anti-IL-15 treats murine lupus by reducing mature and memory B cells
- (2014) Ning Ma et al. CELLULAR IMMUNOLOGY
- Identification of a B cell-dependent subpopulation of multiple sclerosis by measurements of brain-reactive B cells in the blood
- (2014) Stefanie Kuerten et al. CLINICAL IMMUNOLOGY
- Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
- (2014) Masanori Matsumoto et al. IMMUNITY
- Systematic Comparison of Gene Expression between Murine Memory and Naive B Cells Demonstrates That Memory B Cells Have Unique Signaling Capabilities
- (2014) M. M. Tomayko et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
- (2014) M. J. Benson et al. JOURNAL OF IMMUNOLOGY
- Resting Human Memory B Cells Are Intrinsically Programmed for Enhanced Survival and Responsiveness to Diverse Stimuli Compared to Naive B Cells
- (2014) K. L. Good et al. JOURNAL OF IMMUNOLOGY
- Tissue Distribution and Dependence of Responsiveness of Human Antigen-Specific Memory B Cells
- (2014) C. Giesecke et al. JOURNAL OF IMMUNOLOGY
- Transcription Factor ABF-1 Suppresses Plasma Cell Differentiation but Facilitates Memory B Cell Formation
- (2014) Yi-Kai Chiu et al. JOURNAL OF IMMUNOLOGY
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
- (2014) Arumugam Palanichamy et al. JOURNAL OF IMMUNOLOGY
- Progression From IgD+ IgM+ to Isotype-Switched B Cells Is Site Specific during Coronavirus-Induced Encephalomyelitis
- (2014) T. W. Phares et al. JOURNAL OF VIROLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Differential effects of fingolimod on B-cell populations in multiple sclerosis
- (2014) Masakazu Nakamura et al. Multiple Sclerosis Journal
- CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype
- (2014) Griselda V Zuccarino-Catania et al. NATURE IMMUNOLOGY
- CD73 Expression Is Dynamically Regulated in the Germinal Center and Bone Marrow Plasma Cells Are Diminished in Its Absence
- (2014) Laura J. Conter et al. PLoS One
- Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study
- (2014) Nele Claes et al. PLoS One
- Memory B cells contribute to rapid Bcl6 expression by memory follicular helper T cells
- (2014) W. Ise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis
- (2014) Sara J. Ireland et al. JAMA Neurology
- Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood
- (2014) Christopher Hohmann et al. Acta Neuropathologica Communications
- Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trials
- (2013) Paula N. Walsh et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses
- (2013) Maja Jahnmatz et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Effect of interferon beta-1a on B7.1 and B7.2 B-cell expression and its impact on T-cell proliferation
- (2013) Hui Huang et al. JOURNAL OF NEUROIMMUNOLOGY
- The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro
- (2013) Li Li et al. JOURNAL OF NEUROIMMUNOLOGY
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A germinal center–independent pathway generates unswitched memory B cells early in the primary response
- (2012) Justin J. Taylor et al. JOURNAL OF EXPERIMENTAL MEDICINE
- B-Cell Depletion Abrogates T Cell-Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model
- (2012) S. Anwar Jagessar et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Glatiramer Acetate in the Treatment of Multiple Sclerosis
- (2011) Patrice H. Lalive et al. CNS DRUGS
- Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
- (2011) Raquel Planas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Regulatory B10 Cells Differentiate into Antibody-Secreting Cells After Transient IL-10 Production In Vivo
- (2011) D. Maseda et al. JOURNAL OF IMMUNOLOGY
- Alphavirus-Induced Encephalomyelitis: Antibody-Secreting Cells and Viral Clearance from the Nervous System
- (2011) T. U. Metcalf et al. JOURNAL OF VIROLOGY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response
- (2011) K. A. Pape et al. SCIENCE
- The role of antibodies in multiple sclerosis
- (2010) Martin S. Weber et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
- (2010) Christopher T. Harp et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Late B Cell Depletion with a Human Anti-Human CD20 IgG1 Monoclonal Antibody Halts the Development of Experimental Autoimmune Encephalomyelitis in Marmosets
- (2010) Y. S. Kap et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Hierarchy of Maturity of Murine Memory B Cell Subsets
- (2010) M. M. Tomayko et al. JOURNAL OF IMMUNOLOGY
- Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation
- (2010) Barbara Serafini et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- B-Cell Depletion In Vitro and In Vivo with an Afucosylated Anti-CD19 Antibody
- (2010) R. Herbst et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Preferential localization of IgG memory B cells adjacent to contracted germinal centers
- (2010) Y. Aiba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atacicept: targeting B cells in multiple sclerosis
- (2010) Hans-Peter Hartung et al. Therapeutic Advances in Neurological Disorders
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells
- (2009) G. Maarof et al. BLOOD
- Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
- (2009) Yanping Hu et al. IMMUNOLOGY
- B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
- (2009) Sara A. J. Thompson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Multiple layers of B cell memory with different effector functions
- (2009) Ismail Dogan et al. NATURE IMMUNOLOGY
- Interferon- mechanisms of action in multiple sclerosis
- (2009) S. Dhib-Jalbut et al. NEUROLOGY
- Memory and naïve B-cell subsets in patients with multiple sclerosis
- (2009) Masaaki Niino et al. NEUROSCIENCE LETTERS
- Anti-CD20 therapy in patients with rheumatoid arthritis: Predictors of response and B cell subset regeneration after repeated treatment
- (2008) Petra Roll et al. ARTHRITIS AND RHEUMATISM
- BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells
- (2008) G. Badr et al. BLOOD
- Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35–55-induced experimental autoimmune encephalomyelitis
- (2008) Stefanie Kuerten et al. CLINICAL IMMUNOLOGY
- Identification of two subpopulations of purified human blood B cells, CD27− CD23+and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6
- (2008) Fabrice Cognasse et al. IMMUNOLOGY
- Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
- (2008) Takashi Matsushita et al. JOURNAL OF CLINICAL INVESTIGATION
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phenotypic and functional heterogeneity of human memory B cells
- (2008) Iñaki Sanz et al. SEMINARS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search